Key result
The extent of transmural necrosis was independently associated with time to MACEs (HR 1.38; 95% CI 1.19-1.60; P<0.001) and systolic recovery (OR 0.76; 95% CI 0.64-0.92; P=0.004) after STEMI.
Why the study?
Does the extent of transmural necrosis (ETN) predict MACEs and systolic recovery better than dobutamine-stress ejection fraction (EF(D)) in patients with a recent STEMI?
Cohort (n=119)
Does the extent of transmural necrosis (ETN) predict MACEs and systolic recovery better than dobutamine-stress ejection fraction (EF(D)) in patients with a recent STEMI?
Hazard Ratio: 1.38 (95% CI 1.19–1.6)
p-value: p=<.001
The extent of transmural necrosis assessed by cardiac MRI is an independent predictor of MACEs and systolic recovery after STEMI, performing as well as or better than dobutamine-stress ejection fraction.
May support CMR necrosis assessment for post-STEMI risk stratification; leaves open superiority over dobutamine EF.
PURPOSE: To perform a comparison of cardiac magnetic resonance (MR) imaging-derived ejection fraction (EF) during low-dose dobutamine infusion (EF(D)) with the extent of segments with transmural necrosis in more than 50% of their wall thickness (ETN) for the prediction of major adverse cardiac events (MACEs) and late systolic recovery soon after a first ST-segment elevation myocardial infarction (STEMI). MATERIALS AND METHODS: Institutional ethics committee approval and written informed consent were obtained. One hundred nineteen consecutive patients with a first STEMI, a depressed left ventricular EF, and an open infarct-related artery underwent MR imaging at 1 week after infarction. EF(D) and ETN (by using a 17-segment model) were determined, and the prediction of MACEs and systolic recovery at follow-up was assessed by using area under the receiver operating characteristic curve (AUC) and multivariable regression analysis. RESULTS: During follow-up (median, 613 days; range, 312-1243 days), 18 MACEs (five cardiac deaths, six myocardial infarctions, seven readmissions for heart failure) occurred. MACEs were associated with a lower EF(D) (43% +/- 12 [standard deviation] vs 49% +/- 10, P = .02) and a larger ETN (seven segments +/- three vs four segments +/- three, P < .001). Patients with systolic recovery (increase in EF of >5% at follow-up compared with baseline EF, n = 44) displayed a higher EF(D) (51% +/- 10 vs 47% +/- 9, P = .04) and a smaller ETN (three segments +/- two vs five segments +/- three, P = .002) at 1 week. ETN and EF(D) both related to MACEs (AUC: 0.78 vs 0.67, respectively, P = .1) and systolic recovery (AUC: 0.68 vs 0.62, respectively, P = .3). According to multivariable analysis, ETN was the only MR variable associated with time to MACEs (hazard ratio, 1.38; 95% confidence interval: 1.19, 1.60; P < .001) and systolic recovery (odds ratio, 0.76; 95% confidence interval: 0.64, 0.92; P = .004) independent of baseline characteristics. CONCLUSION: ETN is as useful as EF(D) for the prediction of MACEs and systolic recovery soon after STEMI.
No takes yet. Share an insight, caveat, or question.
Bodı́ et al. (2010) conducted a cohort in ST-segment elevation myocardial infarction (STEMI) (n=119). Extent of transmural necrosis (ETN) vs. Ejection fraction during low-dose dobutamine infusion (EF(D)) was evaluated on Time to major adverse cardiac events (MACEs) (HR 1.38, 95% CI 1.19-1.60, p=<.001). The extent of transmural necrosis was independently associated with time to MACEs (HR 1.38; 95% CI 1.19-1.60; P<0.001) and systolic recovery (OR 0.76; 95% CI 0.64-0.92; P=0.004) after STEMI.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: